Dekkers, Claire C. J.
Gansevoort, Ron T.
Heerspink, Hiddo J. L.
Funding for this research was provided by:
University Medical Center Groningen
Article History
First Online: 27 March 2018
Compliance with Ethical Standards
:
: Claire C.J. Dekkers declares that she has no conflict of interest.Ron T. Gansevoort reports grants from Astra Zeneca (manufacturer of the SGLT-2 inhibitor dapagliflozin) and Bayer (manufacturer of MR antagonist finerenone). All money is paid to his employer.Hiddo J.L. Heerspink reports grants and other from AstraZeneca, Boehringer Ingelheim, Janssen, and Abbvie; and other from Fresenius and Merck; all honoraria were paid to his institution.
: This article does not contain any studies with human or animal subjects performed by any of the authors.